comparemela.com

Latest Breaking News On - Christopherj moreau - Page 5 : comparemela.com

Pharmaceutical Company Sets Gold Standard for New Drugs

Pharmaceutical Company Sets Gold Standard for New Drugs

China
United-states
Netherlands
Canada
Japan
Canadian
Amanda-duvall
Jacky-smith
Christopherj-moreau
Pfizer
Us-patent-office
Algernon-pharmaceuticals

Algernon Pharmaceuticals Inc receives Notice of Allowance from US Patent and Trademark Office for Repirinast

Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) said it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO).

China
United-states
Canada
Japan
Christopherj-moreau
Tanabe-pharma
Trademark-office
Algernon-pharmaceuticals-inc
Mitsubishi
Algernon-pharmaceuticals
United-states-patent
Treating-non-alcoholic

Biotech Co. Set To Reach New Highs

Biotech Co. Set To Reach New Highs

Illinois
United-states
Canada
Arizona
Utah
Virginia
Australia
Massachusetts
Oregon
Christopher-bryan
Algernon-pharma
Christopherj-moreau

Algernon NeuroScience Announces U.S. SEC Qualification of Regulation A+ Tier II Offering to Raise up to USD $10M

03.04.2023 - VANCOUVER, British Columbia, April 03, 2023 (GLOBE NEWSWIRE) - Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to . Seite 1

Christopherj-moreau
Issuance-inc
Dalmore-group
Bonus-shares

Algernon Pharmaceuticals Inc says wholly-owned subsidiary's Reg A+ offering gets US SEC qualification

Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) said its wholly-owned subsidiary, Algernon NeuroScience (AGN Neuro), has qualified its Form 1-A.

Canada
Canadian
Algernon-pharma
Christopherj-moreau
Issuance-inc
Algernon-pharmaceuticals-inc
Dalmore-group
Exchange-commission
Algernon-pharmaceuticals
Algernon-neuroscience

vimarsana © 2020. All Rights Reserved.